Value Bridge — NEW YORK-PRESBYTERIAN/BROOKLYN METHO
Current $-33M → Target $-18M (+$14.5M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-32.9M
Current EBITDA
$-18.4M
Target EBITDA
+$14.5M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$3.3M
Payer Mix Optimization
$7.9M
Cost to Collect Reduction
$2.6M
Clean Claim Improvement
$2.0M
Volume & Rate Growth
$13.2M
What This Means
The 7-lever model projects a 0% EBITDA uplift from $-33M to $-18M. The highest-impact lever is Volume & Rate Growth at $5.3M probability-weighted.
IC talking point: "We see $15M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $160M in equity value creation."